US 11324753
Method of treatment of attention deficit/hyperactivity disorder (ADHD)
granted A61KA61K31/00A61K31/5375
Quick answer
US patent 11324753 (Method of treatment of attention deficit/hyperactivity disorder (ADHD)) held by Supernus Pharmaceuticals, Inc. expires Mon May 05 2042 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- Supernus Pharmaceuticals, Inc.
- Grant date
- Tue May 10 2022 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon May 05 2042 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 9
- CPC classes
- A61K, A61K31/00, A61K31/5375, A61P, A61P25/00